Advertisement
Screener

ACADIA PHARMACEUTICALS INC. (ACAD) ROA

ACADIA PHARMACEUTICALS INC. (ACAD) ROA

  • 2026-06-30: ROA 21.83%.
  • 2026-03-31: ROA 23.40%.
  • 2025-12-31: ROA 25.00%.
  • 2025-09-30: ROA 19.63%.

Complete source-backed roa history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-3021.83%
2026-03-3123.40%
2025-12-3125.00%
2025-09-3019.63%
2025-06-3018.13%
2025-03-3120.21%
2024-12-3119.07%
2024-09-3013.15%
2024-06-303.34%
2024-03-31-0.20%
2023-12-31-8.18%
2023-09-30-23.53%
2023-06-30-17.24%
2023-03-31-22.27%
2022-12-31-36.74%
2022-09-30-36.07%
2022-06-30-33.39%
2022-03-31-34.36%
2021-12-31-23.98%
2021-09-30-26.69%
2021-06-30-36.13%
2021-03-31-34.43%
2020-12-31-35.98%
2020-09-30-33.66%
2020-06-30-29.64%
2020-03-31-31.84%
2019-12-31-30.04%
2019-09-30-32.36%
2019-06-30-58.12%
2019-03-31-55.12%
2018-12-31-45.39%
2018-09-30-93.29%
2018-06-30-79.91%
2018-03-31-72.89%
2017-12-31-75.27%
2017-09-30-72.33%
2017-06-30-66.97%
2017-03-31-61.52%
2016-12-31-48.36%
2016-09-30-38.63%
2016-06-30-46.98%
2016-03-31-37.26%
2015-12-31-74.11%
2015-09-30-59.93%
2015-06-30-48.23%
2015-03-31-38.09%
2014-12-31-28.41%
2014-09-30-22.28%
2014-06-30-17.27%
2014-03-31-13.29%
2013-12-31-20.07%
2013-09-30-16.41%
2013-06-30-11.80%
2013-03-31-20.15%
2012-12-31-19.20%
2012-09-30-81.43%
2012-06-30-100.64%
2012-03-31-87.30%
2011-12-31-70.89%
2011-09-3031.54%
2011-06-3030.32%

Annual ROA

DateROA
2025-12-3125.00%
2024-12-3119.07%
2023-12-31-8.18%
2022-12-31-36.74%
2021-12-31-23.98%
2020-12-31-35.98%
2019-12-31-30.04%
2018-12-31-45.39%
2017-12-31-75.27%
2016-12-31-48.36%
2015-12-31-74.11%
2014-12-31-28.41%
2013-12-31-20.07%
2012-12-31-19.20%
2011-12-31-70.89%
2010-12-3139.43%

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47